0001493152-21-002451.txt : 20210203 0001493152-21-002451.hdr.sgml : 20210203 20210203073756 ACCESSION NUMBER: 0001493152-21-002451 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201221 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roberts Brad Michael CENTRAL INDEX KEY: 0001844066 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 21584208 MAIL ADDRESS: STREET 1: 300 CHAFFORD COURT CITY: SIMPSONVILLE STATE: SC ZIP: 29681 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONVERSION LABS, INC. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 3 1 ownership.xml X0206 3 2020-12-21 0 0000948320 CONVERSION LABS, INC. CVLB 0001844066 Roberts Brad Michael C/O CONVERSION LABS, INC, 800 THIRD AVENUE, SUITE 2800 NEW YORK NY 10022 0 1 0 0 Chief Operating Officer Restricted Stock Units 10000 D Options to purchase shares of Common Stock Common Stock, par value $0.001 200000 D Pursuant to the terms of the amended and restated employment agreement, by and between Mr. Roberts and the Issuer, on January 8, 2021 (the "Effective Date"), Mr. Roberts was granted: (i) 10,000 restricted stock units of the Company's common stock (the "RSUs") which shall vest on December 21, 2021; and (ii) stock options to purchase up to 200,000 shares of the Company's common stock at an exercise price of $7.50 per share (the "Stock Options"). 35,000 of the Stock Options vested on the Effective Date, with the remaining Stock Options scheduled to vest in equal monthly tranches, based on the passage of time, over the 30 months following the approval of the Effective Date. /s/ Brad Roberts 2021-02-03